BioSpace News Archive

Deals

Metrion Biosciences Closes Funding Round

Funding to support expansion of ion channel screening capabilities and continued research into potential drugs for auto-immune diseases

April 1, 2019
·
1 min read
Take the Scary out of Summer Storms

Do you find your dog cowering in a corner after a clap of thunder? Does he pace, drool or whine when there is a storm pending? If so, your pooch may be suffering from storm phobia.

April 1, 2019
·
1 min read
Deals

Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments

STRO-001 Ongoing Phase 1 Trial in Myeloma and Lymphoma with Initial Safety Data Expected Mid-2019

April 1, 2019
·
9 min read
Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic

Chondrogenix will use Mogrify’s data-driven conversion platform to generate a safe, efficient and scalable source of cartilage cells for the treatment of osteoarthritis

April 1, 2019
·
2 min read
Nordion and BRIT Collaborate to Bring Cobalt-60 from India to Global Markets

Nordion (Canada) Inc. announces the purchase of Cobalt-60 from the Board of Radiation and Isotope Technology, a unit of the Government of India Department of Atomic Energy, for distribution to Europe.

April 1, 2019
·
2 min read
FDA

AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

AngioDynamics, Inc. announced that the United States Food and Drug Administration approved the Company’s investigational device exemption application for its NanoKnife® Irreversible Electroporation “Direct IRE Cancer Treatment” clinical study.

April 1, 2019
·
9 min read
Policy

Vizient Submits Recommendation to CMS for Changes to Hospital Star Ratings Methodology

In response to the Centers for Medicare and Medicaid Services request for public input on the methodology of the Overall Hospital Quality Star Rating on the Hospital Compare website, Vizient has submitted a detailed proposal for a more clinically grounded approach for the ratings.

April 1, 2019
·
2 min read
Drug Development

BerGenBio: Bemcentinib in Combination With low-dose Chemotherapy Achieves Efficacy Endpoint in AML Patients

Phase II trial evaluating bemcentinib in combination with low-dose chemotherapy in AML patients unfit for intensive therapy

April 1, 2019
·
7 min read
Deals

SpringWorks Therapeutics Completes $125 Million Series B Financing

Three Clinical Trials Expected to Commence in the First Half of 2019, Including Two Late-Stage Rare Oncology Programs and First Targeted Oncology Program in Collaboration with BeiGene

April 1, 2019
·
3 min read
Business

Aerie Pharmaceuticals Announces Appointment of Gianluca Corbinelli as Chief Commercial Officer - Europe

Aerie Pharmaceuticals, Inc. announced the appointment of Gianluca Corbinelli as Chief Commercial Officer - Europe, reporting to Thomas Mitro, Aerie’s President and Chief Operating Officer.

April 1, 2019
·
6 min read